VIMTALABSNSEVimta Labs Limited· PharmaceuticalsLowNeutral
Announced Wed, 29 Apr · 17:48 IST

Vimta Labs Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.1%1-day move
₹451.20
prior close
₹451.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.5-0.5-0.1+6.1+10.2+13.2+11.7+13.7+3.8+0.4+1.5+29.8
Up moveDown movePending
AI summary

Vimta Labs Limited has informed exchanges about a scheduled analyst/investor conference call to discuss Q4 FY2025-26 financial results. The call is set for Wednesday, 6th May 2026 at 4:30 PM IST. The conference call is being hosted by Systematix Institutional Equities, with participation from key management including Managing Director Ms. Harita Vasireddi, Executive Director Mr. Satya Sreenivas Neerukonda, CFO Mr. Siva Rama Krishna Kambhampati, and Company Secretary Ms. Sujani Vasireddi. Dial-in numbers and a Diamond Pass registration link have been provided for participants. The disclosure is made pursuant to Regulation 30 of SEBI LODR Regulations and will be available on the company's website.

Likely market impact

This is a routine earnings call announcement and does not indicate any material corporate action or unusual activity. Shareholders can use this opportunity to engage with management and gain insights into Q4 performance, though the announcement itself has no direct impact on the stock price.